Ascletis Pharma Financial Health

How is Ascletis Pharma's financial position?

Financial Health Score

6/6

Financial Health Score 6/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: 1672's short term assets (CN¥2.6B) exceed its short term liabilities (CN¥100.4M).

Long Term Liabilities: 1672's short term assets (CN¥2.6B) exceed its long term liabilities (CN¥8.5M).


Debt to Equity History and Analysis

Debt Level: 1672 is debt free.

Reducing Debt: 1672 has not had any debt for past 5 years.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: 1672 has sufficient cash runway for more than 3 years based on its current free cash flow.

Forecast Cash Runway: 1672 has sufficient cash runway for more than 3 years if free cash flow continues to grow at historical rates of 2.6% each year


Discover healthy companies